Chemomab Therapeutics Ltd.
Total Trades
12
Buys
8
Sells
4
Largest Trade
$1M+
Insiders
7
Institutional Funds
12
Inst. Value
$500K+
Activist Filings
15
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| OrbiMed Israel GP Ltd. | 10% Owner | SELL | $1M+ | 337K | $3.58 | Jan 5, 2023 |
| Mor George Adi | Chief Scientific O… | SELL | $50K–$100K | 14K | $5.03 | Jan 5, 2023 |
| Cohen Neil Harris | Director | SELL | $1K–$15K | 2K | $2.00 | Nov 18, 2022 |
| Mor George Adi | Chief Scientific O… | SELL | $1M+ | 582K | $2.08 | Nov 17, 2022 |
| Marvin Donald | Executive VP | BUY | $1K–$15K | 500 | $3.27 | Jun 21, 2022 |
| Maryles Joel Michael | Director | BUY | $1K–$15K | 433 | $2.88 | May 25, 2022 |
| Cohen Neil Harris | Director | BUY | $1K–$15K | 2K | $3.19 | May 19, 2022 |
| Maryles Joel Michael | Director | BUY | $1K–$15K | 1K | $4.34 | Mar 21, 2022 |
| Marvin Donald | Executive VP | BUY | $1K–$15K | 1K | $4.04 | Mar 21, 2022 |
| Pfost Dale R | CEO | BUY | $1K–$15K | 3K | $3.98 | Mar 15, 2022 |
| Cohen Neil Harris | Director | BUY | $15K–$50K | 6K | $4.35 | Mar 15, 2022 |
| Darvish Nissim | Director | BUY | $1K–$15K | 1K | $4.28 | Mar 14, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 12 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| ADAR1 Capital Management, LLC | 80K | $100K–$500K | SH |
| ADAR1 Capital Management, LLC | 80K | $100K–$500K | SH |
| Ikarian Capital, LLC | 52K | $50K–$100K | SH |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 52K | $50K–$100K | SH |
| RHUMBLINE ADVISERS | 18K | $15K–$50K | SH |
| JANE STREET GROUP, LLC | 15K | $15K–$50K | SH |
| Virtu Financial LLC | 11K | $15K–$50K | SH |
| BNP PARIBAS FINANCIAL MARKETS | 8K | $1K–$15K | SH |
| MORGAN STANLEY | 4K | $1K–$15K | SH |
| GAMMA Investing LLC | 3K | $1K–$15K | SH |
| UBS Group AG | 2K | $1K–$15K | SH |
| SBI Securities Co., Ltd. | 26 | <$1K | SH |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 2 | <$1K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 17, 2026
4.6%
22.6M shares
SC 13G/A · Aug 7, 2025
3.2%
13.2M shares
SC 13G · Aug 7, 2025
8.4%
32.3M shares
ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP
SC 13D/A · Jun 23, 2025
4.8%
970K shares
SC 13G/A · Apr 10, 2025
4.8%
900K shares
SC 13D/A · Nov 29, 2024
4.8%
898K shares
SC 13G · Nov 21, 2024
6.1%
1.2M shares
OrbiMed Israel BioFund GP Limited Partnership
SC 13D/A · Sep 16, 2024
10.0%
1.9M shares
SC 13G · Aug 20, 2024
6.6%
1.2M shares
OrbiMed Israel BioFund GP Limited Partnership
SC 13D/A · Mar 11, 2024
16.0%
2.3M shares
OrbiMed Israel BioFund GP Limited Partnership
SC 13D/A · Nov 15, 2023
18.3%
2.3M shares
OrbiMed Israel BioFund GP Limited Partnership
SC 13D/A · Jan 5, 2023
19.7%
2.3M shares
SC 13D/A · Nov 17, 2022
6.4%
747K shares
Gabriel Capital Management Ltd.
SC 13G/A · Feb 10, 2022
1.4%
3.1M shares
SC 13D · Jan 20, 2022
11.5%
1.3M shares